Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Deoxycholic Acid (Highly Pure)

<strong>Deoxycholic Acid (Highly Pure)</strong>_x000D_ <strong>Catalog number:</strong> B2010633_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 g_x000D_ <strong>Molecular Weight or Concentration:</strong> 392.57 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool in the sutdy of various metabolic systems_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> 7-Deoxycholic acid, Desoxycholic acid, 3α,12α-Dihydroxy-5β-cholanic acid_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Sung CT, Lee A, Choi F, Juhasz M, Mesinkovska NA. Non-Submental Applications_x000D_ of Injectable Deoxycholic Acid: A Systematic Review. J Drugs Dermatol. 2019 Jul_x000D_ 1;18(7):675-680._x000D_ _x000D_ 2: Farina GA, Cherubini K, de Figueiredo MAZ, Salum FG. Deoxycholic acid in the_x000D_ submental fat reduction: A review of properties, adverse effects, and_x000D_ complications. J Cosmet Dermatol. 2020 Oct;19(10):2497-2504._x000D_ _x000D_ 3: Zarbafian M, Fabi SG. Off-Label Uses of Deoxycholic_Acid in Body Contouring._x000D_ Dermatol Surg. 2020 Oct;46 Suppl 1:S2-S7._x000D_ _x000D_ 4: Dunican KC, Patel DK. Deoxycholic Acid (ATX-101) for Reduction of Submental_x000D_ Fat. Ann Pharmacother. 2016 Oct;50(10):855-61._x000D_ _x000D_ 5: Pham CT, Lee A, Sung CT, Choi F, Juhasz M, Mesinkovska NA. Adverse Events of_x000D_ Injectable Deoxycholic_Acid. Dermatol Surg. 2020 Jul;46(7):942-949._x000D_ _x000D_ 6: Liu M, Chesnut C, Lask G. Overview of Kybella (Deoxycholic_Acid Injection) as_x000D_ a Fat Resorption Product for Submental Fat. Facial Plast Surg. 2019_x000D_ Jun;35(3):274-277._x000D_ _x000D_ 7: Ascher B, Fellmann J, Monheit G. ATX-101 (deoxycholic_acid injection) for_x000D_ reduction of submental fat. Expert Rev Clin Pharmacol. 2016 Sep;9(9):1131-43._x000D_ _x000D_ 8: LaRusso NF, Szczepanik PA, Hofmann AF. Effect of deoxycholic_acid ingestion_x000D_ on bile acid metabolism and biliary lipid secretion in normal subjects._x000D_ Gastroenterology. 1977 Jan;72(1):132-40._x000D_ _x000D_ 9: Marcus SN, Heaton KW. Deoxycholic_acid and the pathogenesis of gall stones._x000D_ Gut. 1988 Apr;29(4):522-33._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/26598242/">_x000D_ 10: Hersant B, Calmon A, Meningaud JP. L'utilisation de l'acide désoxycholique_x000D_ (ATX-101) en médecine esthétique: un traitement prometteur [The use of_x000D_ deoxycholic acid (ATX-101) in aesthetic medicine: A promising treatment]. Rev_x000D_ Stomatol Chir Maxillofac Chir Orale. 2015 Dec;116(6):350-2.</a>_x000D_ _x000D_ <strong>Products Related to Deoxycholic Acid (Highly Pure)</strong><a href="https://moleculardepot.com/product-category/Chemicals/">: Chemicals</a>

Product Specifications

Short Description

Catalog Number: B2010633 (1 g)

Weight

0.8

Length

2

Width

0.9

Height

0.9

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GK Peptide - N-terminal region
MBS3237437-01 0.1 mg

GK Peptide - N-terminal region

Ask
View Details
GK Peptide - N-terminal region
MBS3237437-02 5x 0.1 mg

GK Peptide - N-terminal region

Ask
View Details
Delicious Peptide
070-21 5 mg

Delicious Peptide

Ask
View Details
HIV type 1 Glycoprotein 120 (aa 41 - 520)(R2) [His]
DAG1808-01 100 µg

HIV type 1 Glycoprotein 120 (aa 41 - 520)(R2) [His]

Ask
View Details
HIV type 1 Glycoprotein 120 (aa 41 - 520)(R2) [His]
DAG1808-02 50 ug

HIV type 1 Glycoprotein 120 (aa 41 - 520)(R2) [His]

Ask
View Details
TET2 (NM_001127208) Human Recombinant Protein
PH30403E1 50 µg

TET2 (NM_001127208) Human Recombinant Protein

Ask
View Details